Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease

CONTEXT: High levels of the phosphate regulating hormone, fibroblast growth factor 23 (FGF23), associate with mortality in patients with end-stage renal disease (ESRD), but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of c...

Full description

Saved in:
Bibliographic Details
Main Authors: Isakova, Tamara, Xie, Huiliang, Yang, Wei, Xie, Dawei, Anderson, Amanda Hyre, Scialla, Julia, Wahl, Patricia, Gutiérrez, Orlando M., Steigerwalt, Susan, He, Jiang, Schwartz, Stanley, Lo, Joan, Ojo, Akinlolu, Sondheimer, James, Hsu, Chi-yuan, Lash, James, Leonard, Mary, Kusek, John W., Feldman, Harold I., Wolf, Myles
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124770/
https://ncbi.nlm.nih.gov/pubmed/21673295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.826
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items